Entry Author Date Location
AMAG Pharma Cuts 140 Jobs Amid Restructuring, COVID-19 Disruptions 05/11/20 Boston
MyoKardia’s Heart Drug Shines in Phase 3, FDA Filing Planned for 2021 05/11/20 San Francisco
Dyno Debuts With Plan, Partnerships for Better Gene Therapy Vectors 05/11/20 Boston
Eli Lilly Gets Edge in the “RET” Race With FDA Nod for Cancer Drug 05/08/20 Indiana
2020 National Xconomy Awards Finalists Will Be Announced on June 22 05/08/20 National
Bio Roundup: Acquisitive Alexion, CRISPR on COVID, C. diff Success & More 05/08/20 National
Ayala’s IPO Raises $55M to Test Two Former Bristol Myers Cancer Drugs 05/08/20 National
Trovagene Rebrands as Cardiff Oncology, Promotes Longtime Exec to CEO 05/07/20 San Diego
PTC Therapeutics to Acquire Censa Pharma for Mid-Stage Rare Disease Drug 05/07/20 New York
Novartis Drug Wins FDA Approval for Lung Cancers With Specific Mutation 05/06/20 National
AstraZeneca Diabetes Drug Gets FDA OK for Reducing Heart Health Risks 05/06/20 National
Ventus Launches With $60M to Shine Light on Innate Immune System Drugs 05/06/20 Boston
Encouraging Signals for New Cancer Cell Therapy Strategies 05/06/20 National
Kura Narrows Pipeline After Strategic Review Prompted by COVID-19 05/05/20 San Diego
Alexion Pharma Boosts Blood Drug Lineup With $1.4B Deal for Portola 05/05/20 Boston
COVID-19 and Fungal Superinfections: The Deadly, Perfect Storm 05/05/20 San Diego
Stemline Slated for Acquisition by Menarini in Deal Worth Up to $677M 05/04/20 New York
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs 05/04/20 Boston
Pfizer Pays Valneva $130M for a Bite at a Lyme Disease Vaccine 05/01/20 Europe
FDA Authorizes “Emergency” Use of Gilead’s Remdesivir for Severe COVID-19 05/01/20 National
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses 05/01/20 Boston
Bio Roundup: Remdesivir Data, Erasca’s $200M, a New FDA Nod & More 05/01/20 National
Podcast: How San Diego is Building a Biotech Ecosystem – Genomics & Precision Medicine Experts Weigh in 04/30/20 National
BridgeBio’s Pipeline Expansion Continues as Portfolio’s Milestones Approach 04/30/20 San Francisco
Adicet Aims to Advance CAR-T Therapies in Reverse Merger with resTORbio 04/29/20 Boston
Supernus Makes a Parkinson’s Play With $300M Deal for US WorldMeds Drugs 04/29/20 National
Taysha Launches With $30M to Bring Gene Therapy to CNS Disorders 04/29/20 Texas
At Rome Therapeutics, Kapeller Aims to Turn “Junk” Into New Drugs 04/28/20 Boston
Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill 04/27/20 San Diego
Erasca Lands $200M Mega-Round to Move Cancer Programs to the Clinic 04/27/20 San Diego
Page 2 of 304 « previous page · next page »